Riskpilot← Back to searchSign inGet full accessEGOptiska AB
ABActiveOrg 5565590071Östermalmsgatan 87 ERetail sale of medical and orthopaedic goods · NACE 4774Est. 19988 employees
Revenue 2024
SEK 21,9M
+29% vs 2023
EBITDA margin
6.1%
+374% vs 2023
Equity ratio
13.1%
Financial strength
Net profit 2024
SEK 694K
+3756% vs 2023
| Revenue | SEK 21,9M | +29% |
| EBITDA | SEK 1,3M | +374% |
| Net profit | SEK 694K | +3756% |
| Total assets | SEK 13,6M | +97% |
| Equity | SEK 1,8M | +64% |
| Employees | 8 | — |
Legal name
EGOptiska AB
Org number
5565590071
Legal form
Aktiebolag
NACE code
4774 · Retail sale of medical and orthopaedic goods
Founded
28 augusti 1998
Share capital
SEK 100 000
Employees
8 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Aktiebolaget ska bedriva försäljning av glasögon och solglasögon.
Address
Östermalmsgatan 87 E
Email
ronald.gezang@ego.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 4 482 | 3 280 | 14 421 | 17 014 | 21 941 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 77 | 646 | 1 244 | −485 | 1 330 |
| Depreciation & amort. | −0 | −0 | −0 | −11 | −22 |
| EBIT | 77 | 646 | 1 244 | −496 | 1 308 |
| Net financials | −62 | −65 | −47 | — | −16 |
| Profit before tax | 14 | 433 | 838 | 104 | 1 027 |
| Tax | −7 | −92 | −222 | −86 | −333 |
| Net profit | 7 | 341 | 616 | 18 | 694 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 4 865 | 5 592 | 6 132 | 6 889 | 13 564 |
| Equity | 106 | 447 | 1 063 | 1 081 | 1 775 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 3 886 | 4 124 | 3 688 | 5 027 | 10 743 |
| Total debt | 3 886 | 4 124 | 3 688 | 5 027 | 10 743 |
EBITDA margin
6.1%
This company
15.8%
Market median
-61% vs market
20202024
Equity ratio
13.1%
This company
38.2%
Market median
-66% vs market
20202024
Return on equity
39.1%
This company
18.4%
Market median
+113% vs market
20202024
Net profit margin
3.2%
This company
8.1%
Market median
-60% vs market
20202024
Asset turnover
1.62×
This company
1.12×
Market median
+45% vs market
20202024
Debt / equity
6.64×
This company
0.62×
Market median
-971% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
KS | Audit | 2021 |
| Former (1) | ||
RH Chief Executive Officer | Chief Executive Officer | 2021 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2021 | |
| Board of Directors | 2022 | |
| Former (1) | ||
| Board of Directors | 2021 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2025 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
EGO EYEWEAR LTD
EGOptiska AB (this company)Board members of EGOptiska AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ronald Hans Gezang | Chief Executive Officer | 0 companies |
| Karl Stefan Gustafsson | Audit | 0 companies |
| Sven Gustav Magnus Brisman | Deputy Board Member | 0 companies |
| Anders Sture Feuk | Board of Directors | 0 companies |
| Stephen Tulba | Board of Directors | 0 companies |